Keywords: Biotechnology


Russia develops three new experimental cancer vaccines

Russia is planning to develop three new experimental vaccines targeting different types of cancer, according to Alexander Gintsburg, scientific director of the Gamaleya National Research Center for Epidemiology and Microbiology and a member of the Russian Academy of Sciences. Gintsburg said that future......

Bryan Johnson questions his extreme quest for longevity

American entrepreneur and biotechnology investor Bryan Johnson has sparked widespread debate after acknowledging that his relentless pursuit of extending human life may have gone too far. The 48-year-old businessman, known for his highly controlled lifestyle and ambitious anti-aging program, admitted......

Genetically engineered bacteria offer new hope for pancreatic cancer treatment

Researchers at the University of Chicago have developed a promising experimental approach that could open new avenues in the fight against pancreatic cancer, one of the most difficult cancers to treat with conventional immunotherapy. The strategy uses a genetically modified probiotic bacterium called......

Chinese university launches investigation after reported death in experimental gene therapy trial

A Chinese university has opened an internal investigation following reports that the death of a six-year-old participant in an experimental gene therapy trial was not disclosed in a published scientific study, raising new questions about transparency and ethical standards in clinical research. The inquiry......

Amgen agrees to $74 million settlement in shareholder lawsuit over tax disclosure claims

Biotechnology giant Amgen has agreed to a $74 million settlement in a shareholder lawsuit alleging that the company delayed disclosing a potential $10.7 billion tax liability linked to claims of underreported taxes. The proposed settlement, filed in a federal court in Manhattan, still requires approval......

Tempus to acquire Personalis in $1.5 billion deal to strengthen AI-driven cancer diagnostics

Tempus AI is expanding its presence in precision oncology through a $1.5 billion acquisition of Personalis, a transaction designed to enhance its portfolio of AI-powered cancer diagnostics and genomic testing technologies. The agreement marks another significant step in the growing convergence of artificial......

Nvidia expands AI-driven drug research with new toolkit for scientists

Nvidia has unveiled a new software platform aimed at accelerating scientific research and drug development, further strengthening its position in the rapidly growing intersection of artificial intelligence and life sciences. The company introduced the BioNeMo Agent Toolkit, a solution designed to help......

Eli Lilly to buy Ajax therapeutics for up to $2.3 billion

Eli Lilly and Company has announced an agreement to acquire the privately held biotechnology firm Ajax Therapeutics in a deal valued at up to $2.3 billion in cash. The move strengthens Lilly’s position in the oncology sector, particularly in the development of treatments for rare blood cancers. Ajax......

Eight killed in explosion at Biotech factory in Northern China

An explosion at a biotechnology factory in northern China has left eight people dead, according to local authorities, highlighting ongoing concerns over industrial safety in the region. The incident occurred on Saturday at a production workshop operated by Jiapeng Biotech in Shanyin County, located......